Posted on Oct 12, 2020
Health officials scrambling to produce Trump's ‘last-minute’ drug cards by Election Day
477
10
7
5
5
0
Posted 4 y ago
Responses: 5
SCPO (Join to see)
Looks like it is taking a very narrow analysis of the goal of lowering drug prices and does not account for the “Favored Nations” executive order which aims to lower the cost of certain drugs. Seems like a hit piece.
(1)
(0)
1SG (Join to see)
SCPO (Join to see) - The taxpayer-funded plan would cost $7.9 billion, including about $51 million to create and distribute the cards, and it would allow seniors to use the cards to help cover a portion of their out-of-pocket expenses for up to two years. The government would also spend $19 million sending letters to seniors this month that tout the plan, according to the draft proposal. Officials are still discussing whether that letter will come from Trump himself, said two officials.
The administration has since portrayed the taxpayer-funded drug-discount card plan as a "test" of whether the cards encourage Medicare beneficiaries to more regularly take their medicine while lowering their costs, using what is known as Section 402 authority. The plan has some parallels to a similar proposal that Meadows and other officials, including Medicare innovation chief Brad Smith, negotiated with the pharmaceutical industry this summer. The drug industry ultimately backed away from that plan, worried about the perception of politically aiding Trump’s re-election, The New York Times first reported.
If it happens, I know some who will take the money and vote Biden. No harm no foul i guess.
The administration has since portrayed the taxpayer-funded drug-discount card plan as a "test" of whether the cards encourage Medicare beneficiaries to more regularly take their medicine while lowering their costs, using what is known as Section 402 authority. The plan has some parallels to a similar proposal that Meadows and other officials, including Medicare innovation chief Brad Smith, negotiated with the pharmaceutical industry this summer. The drug industry ultimately backed away from that plan, worried about the perception of politically aiding Trump’s re-election, The New York Times first reported.
If it happens, I know some who will take the money and vote Biden. No harm no foul i guess.
(1)
(0)
Read This Next